Digital health is expanding rapidly across the UAE, making the country one of the most attractive markets for healthtech companies in the region.
The UAE’s digital health sector was valued at USD 619 million in 2023 and is projected to reach USD 2.6 billion by 2030, reflecting strong demand for telemedicine, AI healthcare tools, and digital health platforms. At the same time, the broader healthcare market continues to grow steadily.
Because of its infrastructure and regional connectivity, the UAE is often the first market healthtech companies choose when entering the Middle East. However, the healthcare sector is highly regulated, and companies must navigate licensing, regulatory approvals, and data protection requirements.
1. Why the UAE Healthtech Market Is Growing Rapidly
Several factors are driving the rapid growth of digital health innovation in the UAE.
Government investment in digital healthcare
The UAE government has made healthcare innovation a national priority. Programmes such as the UAE Health Strategy 2030 and national digital health initiatives are accelerating the adoption of telemedicine, artificial intelligence diagnostics, and remote patient monitoring.
Government-backed innovation hubs and healthcare technology funding programmes have also supported the growth of startups and international digital health companies.
A highly connected population
The UAE has one of the most digitally connected populations in the world, with mobile penetration exceeding 180% and near universal internet access among its population of roughly 10 million people. This level of connectivity makes the country an ideal environment for mobile health platforms, teleconsultation services, and AI-powered health tools.
Demand driven by chronic diseases
Chronic conditions such as diabetes, cardiovascular disease, and obesity remain prevalent in the region. These long-term health challenges are creating strong demand for digital therapeutics, preventative health platforms, and remote patient monitoring technologies.
Strategic regional location
Many international companies choose the UAE as their regional headquarters because of its location connecting Europe, Asia, and Africa. From Dubai or Abu Dhabi, healthtech companies can scale into Saudi Arabia, Qatar, Kuwait, and the broader Middle East and North Africa region.
Major healthcare infrastructure investment
In late 2025, Dubai Healthcare City announced a AED 1.3 billion expansion programme, including new medical complexes and innovation facilities. These investments signal the UAE’s long-term commitment to building a global health innovation ecosystem.
2. Understanding the UAE’s Healthcare Regulatory Structure
Unlike some countries with a single national health regulator, the UAE operates under multiple healthcare authorities depending on the emirate where the company operates.
Healthtech founders must first determine which authority will regulate their activities.
Ministry of Health and Prevention (MOHAP)
MOHAP is the federal healthcare regulator and governs healthcare activities in the Northern Emirates, including:
Sharjah
Ajman
Ras Al Khaimah
Fujairah
Umm Al Quwain
MOHAP also sets many of the national healthcare standards that apply across the country.
Dubai Health Authority (DHA)
Companies operating healthcare services in Dubai must obtain approvals from the Dubai Health Authority (DHA). DHA regulates telemedicine, digital clinical services, healthcare facilities, and professional licensing within the emirate.
Many international healthtech companies start in Dubai because the DHA has established clear digital health frameworks and telemedicine licensing models.
Department of Health – Abu Dhabi (DOH)
The Department of Health (DOH) regulates healthcare operations in Abu Dhabi. It oversees licensing, healthcare providers, and digital health services across the emirate’s public and private healthcare system.
Abu Dhabi is particularly attractive for healthtech companies looking to work with government hospital networks and large healthcare institutions.
Importantly, licenses issued by one emirate’s regulator do not automatically allow operations in another. Companies expanding across multiple emirates may need separate regulatory approvals.
3. Choosing the Right Business Structure: Free Zone or Mainland
Free zone companies
Free zones allow 100% foreign ownership and simplified company formation procedures.
Several UAE free zones are particularly relevant for healthtech businesses.
- Dubai Healthcare City (DHCC)
One of the world’s largest healthcare free zones, DHCC is designed specifically for healthcare providers, medical research organisations, and healthtech companies. It offers specialised facilities such as telemedicine infrastructure, clinical research centres, and healthcare innovation programmes. - Dubai Silicon Oasis (DSO)
DSO is often chosen by software-focused healthtech startups developing AI diagnostics platforms, healthcare SaaS tools, and digital health analytics systems. - Abu Dhabi Global Market (ADGM)
ADGM operates under an English Common Law legal framework and offers a strong regulatory environment for companies handling sensitive data or seeking access to institutional investors. - Hub71 Abu Dhabi
Hub71 is a government-backed innovation hub that offers subsidised office space, funding opportunities, and ecosystem support for technology startups, including healthtech companies.
Mainland companies
Mainland companies are licensed by the Department of Economic Development (DED) in each emirate. Following reforms to UAE company law in 2021, most business activities now allow 100% foreign ownership on the mainland.
Mainland entities are often preferable for companies planning to work directly with government healthcare providers, insurance companies, or public sector institutions.
4. Regulatory Approvals for Digital Health and Telemedicine
Not all healthtech companies require the same level of regulatory approval. The requirements depend largely on whether the platform interacts directly with patients or handles regulated medical data.
- Technology-only health platforms
Companies providing software solutions such as electronic health record systems, healthcare analytics platforms, or B2B SaaS infrastructure may operate under a standard technology licence.
However, they must still comply with UAE health data laws.
- Telemedicine and remote consultations
Platforms that provide teleconsultation services or digital clinical care must obtain approval from the relevant healthcare authority, such as DHA or DOH.
Recent regulatory updates introduced stricter requirements for telemedicine platforms, including data privacy compliance, platform security standards, and healthcare professional licensing rules.
- Medical devices and AI diagnostics
Healthtech products classified as medical devices or diagnostic tools are regulated under Federal Decree-Law No. 38 of 2024 on Medical Products.
Products such as AI diagnostic software, connected medical wearables, or digital therapeutic platforms may require formal marketing approval from MOHAP before they can be sold or used in the UAE.
Approval timelines typically range from three to twelve months, depending on the complexity of the product and whether it has already received regulatory approval in other countries.
5. Health Data Compliance in the UAE
Health data protection is a central part of the regulatory framework for digital health in the UAE. Any healthtech company operating in the country must understand how patient information is managed, stored, and protected under local laws.
Medical data in the UAE is primarily governed by the Healthcare ICT Law (Federal Law No. 2 of 2019), which regulates the use of technology in healthcare and establishes strict standards for handling patient information. These rules apply not only to hospitals and clinics but also to telemedicine platforms, digital health applications, and other healthtech services that process medical data.
In addition, the UAE Personal Data Protection Law (PDPL) introduced in 2021 regulates the broader handling of personal data across different sectors. However, healthcare data is largely governed by the Healthcare ICT Law due to the sensitive nature of medical information.
As a result, healthtech companies entering the UAE must ensure their data infrastructure and technology platforms align with the country’s healthcare data governance framework before launching services in the market.
6. Typical Costs and Timelines for Healthtech Expansion
Healthtech founders should plan realistically for the cost and timeline of entering the UAE market.
Estimated setup costs
Typical company formation costs may include:
Free zone healthtech entity: AED 30,000 – AED 80,000
Technology-focused startup entity: AED 25,000 – AED 60,000
Abu Dhabi innovation ecosystem programmes: AED 10,000 – AED 50,000
Mainland company setup: AED 15,000 – AED 40,000
Additional regulatory approvals for telemedicine or clinical services can add AED 10,000 to AED 50,000.
Companies should also budget for data compliance upgrades, cloud migration, and regulatory advisory services, which can vary depending on the complexity of the platform.
Typical timelines
Estimated timelines for launching in the UAE include:
Technology platform without clinical services: 6–10 weeks
Telemedicine or digital clinical platform: 4–10 months
Medical device approval: up to 12 months
Companies planning clinical services should ideally begin regulatory engagement six months before their planned market launch.
7. Building a Successful Position in the UAE Healthtech Ecosystem
Beyond regulatory approval, long-term success in the UAE often depends on building strong ecosystem relationships.
Government partnerships
Government institutions are major healthcare stakeholders in the UAE. Engaging early with health authorities such as DHA and DOH can create opportunities for pilot programmes, innovation partnerships, and procurement projects.
Insurance partnerships
Health insurance is mandatory in Dubai and Abu Dhabi, making insurers a critical distribution channel for digital health solutions.
Working with insurers such as Daman, Aetna International, and MetLife can help healthtech companies establish reimbursement pathways for digital health services.
Clinical and research collaboration
Partnerships with internationally recognised healthcare institutions — such as Cleveland Clinic Abu Dhabi and Moorfields Eye Hospital — can support clinical validation, research studies, and regulatory approval processes.
Startup accelerators and innovation programmes
Government-backed programmes such as Hub71 Health, Dubai Future Accelerators, and DHCC innovation initiatives provide valuable support through funding, mentorship, and access to healthcare networks.
A Market That Rewards Structured Entry
The UAE healthtech market offers strong opportunities for companies with scalable digital health solutions. Government investment, growing healthcare demand, modern infrastructure, and strong regional connectivity make the country an attractive destination for healthtech expansion.
Companies that succeed in the UAE usually take a structured approach. They choose the right business jurisdiction based on regulatory and commercial needs, start regulatory approvals early, ensure their data systems comply with local rules, and build strong relationships with government authorities, insurers, and healthcare institutions.
While the regulatory environment can be complex, it is manageable with the right preparation. For companies that plan carefully, the UAE provides a growing market with strong demand and expanding healthcare infrastructure.
For healthtech founders, the real challenge is not deciding whether to enter the UAE — but ensuring their market entry strategy is well planned to capture the opportunity.
